TY - JOUR
T1 - Isolation of cancer cells by "in situ" microfluidic biofunctionalization protocols
AU - De Vitis, Stefania
AU - Matarise, Giuseppina
AU - Pardeo, Francesca
AU - Catalano, Rossella
AU - Malara, Natalia Maria
AU - Trunzo, Valentina
AU - Tallerico, Rossana
AU - Gentile, Francesco T.
AU - Candeloro, Patrizio
AU - Coluccio, Maria Laura
AU - Massaro, Alessandro S.
AU - Viglietto, Giuseppe
AU - Carbone, Ennio
AU - Kutter, Jörg Peter
AU - Perozziello, Gerardo
AU - Di Fabrizio, Enzo M.
N1 - KAUST Repository Item: Exported on 2020-10-01
Acknowledgements: This work was partially supported by the project PON "Nuove strategie nanotecnologiche per la messa a punto di farmaci e presidi diagnostici diretti verso cellule cancerose circolanti" (code: PON01_02782), the European project EUROMBR (grant agreement n.608104), the project for Young Researchers financed from the Italian Ministry of Health (CUP J65C13001350001, project n. GR-2010-2311677) and the project FIRB "ReteNazionale di Ricerca sulle Nanoscienze ItalNanoNet" (code: RBPR05JH2P_010, CUP B41J09000110005) granted to the nanotechnology laboratory of the Department of Experimental Medicine of the University of Magna Graecia of Catanzaro.
PY - 2014/7
Y1 - 2014/7
N2 - The aim of this work is the development of a microfluidic immunosensor for the immobilization of cancer cells and their separation from healthy cells by using "in situ" microfluidic biofunctionalization protocols. These protocols allow to link antibodies on microfluidic device surfaces and can be used to study the interaction between cell membrane and biomolecules. Moreover they allow to perform analysis with high processing speed, small quantity of reagents and samples, short reaction times and low production costs. In this work the developed protocols were used in microfluidic devices for the isolation of cancer cells in heterogeneous blood samples by exploiting the binding of specific antibody to an adhesion protein (EpCAM), overexpressed on the tumor cell membranes. The presented biofunctionalization protocols can be performed right before running the experiment: this allows to have a flexible platform where biomolecules of interest can be linked on the device surface according to the user's needs. © 2014 Elsevier B.V. All rights reserved.
AB - The aim of this work is the development of a microfluidic immunosensor for the immobilization of cancer cells and their separation from healthy cells by using "in situ" microfluidic biofunctionalization protocols. These protocols allow to link antibodies on microfluidic device surfaces and can be used to study the interaction between cell membrane and biomolecules. Moreover they allow to perform analysis with high processing speed, small quantity of reagents and samples, short reaction times and low production costs. In this work the developed protocols were used in microfluidic devices for the isolation of cancer cells in heterogeneous blood samples by exploiting the binding of specific antibody to an adhesion protein (EpCAM), overexpressed on the tumor cell membranes. The presented biofunctionalization protocols can be performed right before running the experiment: this allows to have a flexible platform where biomolecules of interest can be linked on the device surface according to the user's needs. © 2014 Elsevier B.V. All rights reserved.
UR - http://hdl.handle.net/10754/563614
UR - https://linkinghub.elsevier.com/retrieve/pii/S0167931714001543
UR - http://www.scopus.com/inward/record.url?scp=84901836503&partnerID=8YFLogxK
U2 - 10.1016/j.mee.2014.04.013
DO - 10.1016/j.mee.2014.04.013
M3 - Article
SN - 0167-9317
VL - 124
SP - 76
EP - 80
JO - Microelectronic Engineering
JF - Microelectronic Engineering
ER -
